Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community

Other illness

• ③Patient cannot be followed up for 36 months (due to health condition or migration);
• ⑤Type 1 diabetes;

Lab values

• ②eGFR\<30 mL/min/1.73m2 (CKD-EPI formula);

Other

• ①Pregnant women or women planning to become pregnant;
• ④Unwilling or unable to sign the informed consent;

• ①Males or females aged 65 and above (≥65) receive treatment from the local community health service center;
• ②Diagnosed type 2 diabetes (ADA criteria):
• A. Typical symptoms of diabetes + random blood sugar ≥ 11.1mmol/L;
• B. Fasting blood glucose (FPG) ≥ 7.0mmol/L (fasting blood glucose is defined as no caloric intake within 8 hours);
• C. Oral glucose tolerance test 2h blood glucose (OGTT) ≥ 11.1mmol/L (2h after meal);
• D. have been treated with antidiabetic drugs;
• Each blood sugar test must be repeated to confirm the diagnosis;
• ③Complicated with chronic kidney disease and/or very high/high risk of cardiovascular disease, meet any one of the following:
• A. ASCVD, including coronary heart disease, cerebral infarction, peripheral vascular disease;
• B. Or target organ damage (albuminuria, renal impairment with eGFR ≥ 30 ml/min/1.73m2, left ventricular hypertrophy or retinopathy);
• C. ≥ 3 major risk factors (age ≥ 65 years old, hypertension, dyslipidemia, smoking, obesity );
• D. Diabetes duration ≥ 10 years, with any one traditional cardiovascular risk factor such as advanced age, obesity, smoking, sedentary, family history of cardiovascular disease, hypertension, abnormal lipid metabolism.